InvestorsHub Logo
Followers 8
Posts 1891
Boards Moderated 0
Alias Born 05/05/2016

Re: Straightshot post# 10893

Tuesday, 02/27/2018 9:25:04 AM

Tuesday, February 27, 2018 9:25:04 AM

Post# of 44784

The puzzling thing about these positive readouts is they are only worth 3 or 4 cents...

Think about what it's going to be worth when the medical
community and desperate patients discover the tremendous
therapeutic potential of PLX-R18.

Think about all the circumstances where hematological support
is indicated, from chemotherapy, radiation treatments and the
battlefield (or civilian casualties in a dirty bomb attack).

We're talking about multi-billion dollar markets, and a meteoric
rise for Pluristem. Every new piece of data, from diverse medical
and scientific sources adds to the probability of this treatment
proving itself to be effective (and we just got one more !)

The fact that the market does not see it at this point is advantageous
for those of us who discovered this incredible company recently.
(sorry about the "DEAD MONEY" people, ten years ago was definitely
way too early to invest, so I can understand the anger and bitterness,
though not the need to inflict it on this board).

Anyway, who ever said that the market is efficient, it's not, that's
why every now and then, you get lucky and find a Pluristem while
it's still very affordable.

Good luck,
zzaatt.